Sympathetic nervous system behavior in human obesity

Neuroscience and Biobehavioral Reviews

Volumn 33, Issue 2, 2009, Pages 116-124

  Davy, Kevin P ^a   Orr, Jeb S ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Adiposity; Autonomic nervous system; Muscle sympathetic nerve activity

Indexed keywords

NORADRENALIN;

ADRENERGIC SYSTEM; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; ELECTRONEUROLOGY; HOMEOSTASIS; HUMAN; INTRAABDOMINAL FAT; METABOLIC DISORDER; METABOLIC REGULATION; NEUROANATOMY; NEUROMUSCULAR SYSTEM; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKELETAL MUSCLE; WEIGHT CHANGE; WEIGHT GAIN;

ENERGY METABOLISM; HUMANS; INTRA-ABDOMINAL FAT; KIDNEY; MUSCLE, SKELETAL; OBESITY; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; WEIGHT GAIN;

EID: 56949098667     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2008.05.024     Document Type: Review

References (81)

1. Ahima R.S., and Flier J.S. Leptin. Annu. Rev. Physiol. 62 (2000) 413-437
2. Alvarez G.E., Beske S.D., Ballard T.P., and Davy K.P. Sympathetic neural activation in visceral obesity. Circulation 106 (2002) 2533-2536
3. Alvarez G.E., Ballard T.P., Beske S.D., and Davy K.P. Subcutaneous obesity is not associated with sympathetic neural activation. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H414-418
4. Anderson E., Hoffman R., Balon T., Sinkey C., and Mark A. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87 (1991) 2246-2252
5. Arrone L., Mackintosh R., Rosenbaum M., Leibel R., and Hirsch J. Autonomic nervous system activity in weight gain and weight loss. Am. J. Physiol. Regul. Integr. Comp. Physiol. 269 (1995) R222-R225
6. Bartness T.J., and Song C.K. Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue. J. Lipid Res. 48 (2007) 1655-1672
7. Benedict C., Dodt C., Hallschmid M., Lepiorz M., Fehm H.L., Born J., and Kern W. Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metabolism 54 (2005) 1356-1361
8. Bjorntorp P., Holm G., Rosmond R., and Folkow B. Hypertension and the metabolic syndrome: closely related central origin?. Blood Press. 9 (2000) 71-82
9. Bray G.A. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J. Nutr. 121 (1991) 1146-1162
10. Cannon W. Bodily Changes in Pain, Hunger, Fear, and Rage (1915), Appleton, New York pp. 22-39
11. Charkoudian N., Joyner M.J., Johnson C.P., Eisenach J.H., Dietz N.M., and Wallin B.G. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J. Physiol. 568 (2005) 315-321
12. Coppack S.W., Horowitz J.F., Paramore D.S., Cryer P.E., Royal H.D., and Klein S. Whole body, adipose tissue, and forearm norepinephrine kinetics in lean and obese women. Am. J. Physiol. Endo. Metab. 275 (1998) E830-834
13. Davy K.P., and Hall J.E. Obesity and hypertension: two epidemics or one?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R803-813
14. Dimsdale J., and Ziegler M. What do plasma and urinary measures of catecholamines tell us about human response to stress?. Circulation 83 Suppl. II (1991) II-36-II-42
15. Dodt C., Wallin G., Fehm H.L., and Elam M. The stress hormone adrenocorticotropin enhances sympathetic outflow to the muscle vascular bed in humans. J. Hypertens. 16 (1998) 195-201
16. Dodt C., Lonnroth P., Fehm H.L., and Elam M. Intraneural stimulation elicits an increase in subcutaneous interstitial glycerol levels in humans. J. Physiol. 521 Pt 2 (1999) 545-552
17. Dodt C., Lonnroth P., Fehm H.L., and Elam M. The subcutaneous lipolytic response to regional neural stimulation is reduced in obese women. Diabetes 49 (2000) 1875-1879
18. Eisenhofer G., Esler M.D., Meredith I.T., Dart A., Cannon III R.O., Quyyumi A.A., Lambert G., Chin J., Jennings G.L., and Goldstein D.S. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation 85 (1992) 1775-1785
19. Engeli S., Negrel R., and Sharma A.M. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35 (2000) 1270-1277
20. Esler M., Jennings G., Korner P., Willett I., Dudley F., Hasking G., Anderson W., and Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11 (1988) 3-20
21. Esler M., Jennings G., Lambert G., Meredith I., Horne M., and Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev. 70 (1990) 963-985
22. Esler M., Rumantir M., Wiesner G., Kaye D., Hastings J., and Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am. J. Hypertens. 14 (2001) 304S-309S
23. Esler M., Hastings J., Lambert G., Kaye D., Jennings G., and Seals D.R. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R909-916
24. Ferrier C., Esler M.D., Eisenhofer G., Wallin B.G., Horne M., Cox H.S., Lambert G., and Jennings G.L. Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension 19 (1992) 62-69
25. Finkelstein E.A., Fiebelkorn I.C., and Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying?. Health Aff. (Millwood) (2003) Suppl:W3-219-226
26. Gentile C.L., Orr J.S., Davy B.M., and Davy K.P. Modest weight gain is associated with sympathetic neural activation in nonobese humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 (2007) R1834-1838
27. Gothert M. Modulation of noradrenaline release in human cardiovascular tissues. Pharmacol. Toxicol. 92 (2003) 156-159
28. Grassi G., Bolla G., Seravalle G., Turri C., Lanfranchi A., and Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin. Sci. (Lond.) 92 (1997) 285-289
29. Grassi G., Seravalle G., Colombo M., Bolla G., Cattaneo B., Cavagnini F., and Mancia G. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 97 (1998) 2037-2042
30. Grassi G., Seravalle G., Dell'Oro R., Turri C., Bolla G.B., and Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 36 (2000) 538-542
31. Grassi G., Seravalle G., Dell'Oro R., Turri C., Pasqualinotto L., Colombo M., and Mancia G. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 38 (2001) 1316-1320
32. Grassi G., Seravalle G., Dell'Oro R., Trevano F.Q., Bombelli M., Scopelliti F., Facchini A., and Mancia G. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J. Hypertens. 21 (2003) 1761-1769
33. Grassi G., Facchini A., Trevano F.Q., Dell'Oro R., Arenare F., Tana F., Bolla G., Monzani A., Robuschi M., and Mancia G. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46 (2005) 321-325
34. Gudbjornsdottir S., Lonnroth P., Sverrisdottir Y., Wallin B., and Elam M. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension 27 (1996) 276-280
35. Hall J.E. The kidney, hypertension, and obesity. Hypertension 41 (2003) 625-633
36. Haynes W.G. Interaction between leptin and sympathetic nervous system in hypertension. Curr. Hypertens. Rep. 2 (2000) 311-318
37. Huggett R.J., Scott E.M., Gilbey S.G., Bannister J., Mackintosh A.F., and Mary D.A. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 48 (2005) 172-179
38. Jern S. Hemodynamics of the male fat distribution pattern. Blood Press. 1 (1992) 21-29
39. Jones P.P., Snitker S., Skinner J.S., and Ravussin E. Gender differences in muscle sympathetic nerve activity: effect of body fat distribution. Am. J. Physiol. Endo. Metab. 270 (1996) E363-366
40. Jones P.P., Davy K.P., Alexander S., and Seals D.R. Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity. Am. J. Physiol. Endo. Metab. 272 (1997) E976-E980
41. Jones P.P., Davy K.P., and Seals D.R. Relations of total and abdominal adiposity to muscle sympathetic nerve activity in healthy older males. Int. J. Obes. Relat. Metab. Disord. 21 (1997) 1053-1057
42. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., and Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J. Am. Coll. Cardiol. 26 (1995) 1257-1263
43. Klein S., Young V.R., Blackburn G.L., Bistrian B.R., and Wolfe R.R. The impact of body composition on the regulation of lipolysis during short-term fasting. J. Am. Coll. Nutr. 7 (1988) 77-84
44. Kopin I.J. Catecholamine metabolism: basic aspects and clinical significance. Pharmacol. Rev. 37 (1985) 333-364
45. Lambert G.W., Kaye D.M., Lefkovits J., Jennings G.L., Turner A.G., Cox H.S., and Esler M.D. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients. Circulation 92 (1995) 1813-1818
46. Lambert G.W., Vaz M., Cox H.S., Turner A.G., Kaye D.M., Jennings G.L., and Esler M.D. Human obesity is associated with a chronic elevation in brain 5-hydroxytryptamine turnover. Clin. Sci. (Lond.) 96 (1999) 191-197
47. Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q. J. Med. 61 (1986) 1081-1090
48. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
49. Loewy A., and Spyder K. Central Regulation of Autonomic Functions (1990), Oxford University Press, New York
50. Macefield V.G., Elam M., and Wallin B.G. Firing properties of single postganglionic sympathetic neurones recorded in awake human subjects. Auton. Neurosci. 95 (2002) 146-159
51. Matsukawa T., Gotoh E., Minamisawa K., Kihara M., Ueda S., Shionoiri H., and Ishii M. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am. J. Physiol. 261 (1991) R690-696
52. Miyajima E., Shigemasa T., Yamada Y., Tochikubo O., and Ishii M. Angiotensin II blunts, while angiotensin converting enzyme inhibitor augments, reflex sympathetic inhibition in humans. Clin. Exper. Pharmacol. Physiol. 26 (1999) 797-802
53. Monroe M.B., Van Pelt R.E., Schiller B.C., Seals D.R., and Jones P.P. Relation of leptin and insulin to adiposity-associated elevations in sympathetic activity with age in humans. Int. J. Obes. Relat. Metab. Disord. 24 (2000) 1183-1187
54. Morrison S.F. Differential control of sympathetic outflow. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R683-698
55. Narkiewicz K., van de Borne P.J., Cooley R.L., Dyken M.E., and Somers V.K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98 (1998) 772-776
56. Ng A.V., Callister R., Johnson D.G., and Seals D.R. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21 (1993) 498-503
57. Peeters A., Barendregt J.J., Willekens F., Mackenbach J.P., Al Mamun A., and Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern. Med. 138 (2003) 24-32
58. Ravussin E., and Tataranni P.A. The role of altered sympathetic nervous system activity in the pathogenesis of obesity. Proc. Nutr. Soc. 55 (1996) 793-802
59. Reid I.A. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol. Endo. Metab. 262 (1992) E763-778
60. Rumantir M.S., Vaz M., Jennings G.L., Collier G., Kaye D.M., Seals D.R., Wiesner G.H., Brunner-La Rocca H.P., and Esler M.D. Neural mechanisms in human obesity-related hypertension. J. Hypertens. 17 (1999) 1125-1133
61. Russell C.D., Petersen R.N., Rao S.P., Ricci M.R., Prasad A., Zhang Y., Brolin R.E., and Fried S.K. Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone. Am. J. Physiol. Endo. Metab. 275 (1998) E507-515
62. Scherrer U., and Owlya R. Sympathetic-nerve activity before and after resection of an insulinoma. N. Engl. J. Med. 335 (1996) 1240-1242
63. Scherrer U., Randin D., Tappy L., Vollenweider P., Jequier E., and Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 89 (1994) 2634-2640
64. Schlaich M.P., Kaye D.M., Lambert E., Sommerville M., Socratous F., and Esler M.D. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 108 (2003) 560-565
65. Schwartz M.W., and Porte Jr. D. Diabetes, obesity, and the brain. Science 307 (2005) 375-379
66. Schwartz R.S., Jaeger L.F., Veith R.C., and Lakshminarayan S. The effect of diet or exercise on plasma norepinephrine kinetics in moderately obese young men. Int. J. Obes. Relat. Metab. Disord. 14 (1990) 1-11
67. Snitker S., Pratley R.E., Nicolson M., Tataranni P.A., and Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes. Res. 5 (1997) 338-340
68. Spraul M., Ravussin E., Fontvieille A.M., Rising R., Larson D.E., and Anderson E.A. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J. Clin. Invest. 92 (1993) 1730-1735
69. Spraul M., Anderson E.A., Bogardus C., and Ravussin E. Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes 43 (1994) 191-196
70. Straznicky N.E., Lambert E.A., Lambert G.W., Masuo K., Esler M.D., and Nestel P.J. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J. Clin. Endocrinol. Metab. 90 (2005) 5998-6005
71. Trombetta I.C., Batalha L.T., Rondon M.U., Laterza M.C., Kuniyoshi F.H., Gowdak M.M., Barretto A.C., Halpern A., Villares S.M., and Negrao C.E. Weight loss improves neurovascular and muscle metaboreflex control in obesity. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H974-982
72. Vallbo A.B., Hagbarth K.E., and Wallin B.G. Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J. Appl. Physiol. 96 (2004) 1262-1269
73. Vaz M., Jennings G., Turner A., Cox H., Lambert G., and Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96 (1997) 3423-3429
74. Vgontzas A.N., Bixler E.O., and Chrousos G.P. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J. Intern. Med. 254 (2003) 32-44
75. von Euler U. Identification of the sympathomimetic ergone in adrenergic nerves of cattle (sympathin N) with laevo-nor-adrenaline. Acta Physiol. Scand. 16 (1948) 63-74
76. Wallin B., and Kunimoto M.J.S. Possible genetic influence on the strength of human muscle nerve sympathetic activity at rest. Hypertension 22 (1993) 282-284
77. Wallin B.G., and Fagius J. Peripheral sympathetic neural activity in conscious humans. Ann. Rev. Physiol. 50 (1988) 565-576
78. Weyer C., Pratley R.E., Snitker S., Spraul M., Ravussin E., and Tataranni P.A. Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension 36 (2000) 531-537
79. World Health Organization. (1997) Preventing and managing the global epidemic: Report of a World Health Organization Consultation on Obesity. Geneva.
80. Young J., and Macdonald I. Sypathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int. J. Obes. Relat. Metab. Disord. 16 (1992) 959-967
81. Young T., Peppard P.E., and Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med. 165 (2002) 1217-1239